Karl Storz Endoscopy Recalls

All product recalls associated with Karl Storz Endoscopy.

Get alerts for this brand

Recall Summary

Total Recalls

77

Past Year

0

Class I (Serious)

0

Most Recent

Dec 2024

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–20 of 77 recalls

KARL STORZ Uretero-Renoscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

KARL STORZ Cysto-Urethroscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

Karl Storz Endoskope Biopsy Forceps (Karl Storz) – Cleaning Validation Failure (2024)

Due to failure of manual cleaning validation, biopsy and grasping forceps like sterility assurance.

FDADec 19, 2024AZ, AR, CA +29 more

• Karl Storz Endoscopy

KARL STORZ Uretero-Renoscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

KARL STORZ Pediatric Uretero-Renoscope (Karl Storz) – Reprocessing Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

KARL STORZ Uretero-Renoscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

KARL STORZ Uretero-Renoscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

KARL STORZ Uretero-Renoscope (Karl Storz) – Reprocessing Modality Issue (2024)

Scope IFUs contain a reprocessing modalities that have not been reviewed and/or approved for safety and efficacy by the FDA.

FDADec 19, 2024Nationwide• Karl Storz Endoscopy

Karl Storz Irrigation Tubing (Karl Storz) – Labeling Error (2024)

Due to improper labeling of products. An intended use on the label has not been reviewed and approved by FDA for distribution in the U.S.

FDAOct 21, 2024Nationwide• Karl Storz Endoscopy

Karl Storz Aggressive Cutter (Karl Storz) – Sterility Barrier Breach (2024)

Due to holes detected in the inner barrier system that may compromise the sterility of the affected products.

FDAOct 11, 2024Nationwide• Karl Storz Endoscopy